Topic: Webinar in Progress Now! CEACAM6 as a Biological Marker and Prognosti
In 2011, The Cholangiocarcinoma Foundation funded two grants through the Conquer Cancer Foundation: the Young Investigator Award and the Long Term International Fellowship Award. The Young Investigator Award was presented to Dr. Flavio Rocha, who has recently moved from the Memorial Sloan-Kettering Cancer Center in New York to the Virginia Mason Medical Center in Seattle. Dr. Rocha is using the $50,000 grant from The Cholangiocarcinoma Foundation to investigate CEACAM6 as a biological marker and prognostic factor for biliary malignancy. We are pleased to have Dr. Rocha joining us today to provide an update on this study. The Cholangiocarcinoma Foundation invites you to join us today for this webinar.
To join us, please go to the following link: https://www1.gotomeeting.com/register/222206536